Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
4-1BB
Description:
A T-cell costimulatory receptor encoded by TNFRSF9, also called CD137, that contributes to immune-cell activation and is studied in immunology and cancer therapy.
Related topics:
CAR-T cell therapy research (20%),
Cancer Immunotherapy and Biomarkers (19%),
T-cell and B-cell Immunology (13%),
Immunotherapy and Immune Responses (8%)
Wikidata ID:
wiki/Q14913226
OpenAlex ID:
keywords/4-1bb
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
2010
·
Richard A Morgan
, James C Yang
, et al.
·
Molecular Therapy
·
2,603
PDF
Global characterization of T cells in non-small-cell lung cancer by single-cell sequencing
2018
·
Xinyi Guo
, Yuanyuan Zhang
, et al.
·
Nature Medicine
·
1,799
Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
2016
·
Omkar U. Kawalekar
, Roddy S. O’Connor
, et al.
·
Immunity
·
1,289
PDF
Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
2009
·
Michael C. Milone
, Jonathan D. Fish
, et al.
·
Molecular Therapy
·
1,232
PDF
PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors
2014
·
Alena Gros
, Paul F. Robbins
, et al.
·
Journal of Clinical Investigation
·
1,160
PDF
The role of TNF superfamily members in T-cell function and diseases
2009
·
Michael Croft
·
Nature reviews. Immunology
·
948
Enhancing immunotherapy in cancer by targeting emerging immunomodulatory pathways
2021
·
Lukas Kraehenbuehl
, Chien-Huan Weng
, et al.
·
Nature Reviews Clinical Oncology
·
919
Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
1997
·
Ignacio Melero
, Walter W. Shuford
, et al.
·
Nature Medicine
·
913
Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?
2003
·
Michael Croft
·
Nature reviews. Immunology
·
880
Structural Design of Engineered Costimulation Determines Tumor Rejection Kinetics and Persistence of CAR T Cells
2015
·
Zeguo Zhao
, Maud Condomines
, et al.
·
Cancer Cell
·
875
PDF
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
2004
·
C Imai
, K Mihara
, et al.
·
Leukemia
·
871
Next generation of immune checkpoint therapy in cancer: new developments and challenges
2018
·
Julian A. Marin-Acevedo
, Bhagirathbhai Dholaria
, et al.
·
Journal of Hematology & Oncology
·
836
PDF
The head and neck cancer immune landscape and its immunotherapeutic implications
2016
·
Rajarsi Mandal
, Yasin Şenbabaoğlu
, et al.
·
JCI Insight
·
810
PDF
4-1BB Costimulatory Signals Preferentially Induce CD8+ T Cell Proliferation and Lead to the Amplification In Vivo of Cytotoxic T Cell Responses
1997
·
Walter W. Shuford
, Kerry Klussman
, et al.
·
The Journal of Experimental Medicine
·
805
PDF
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
2017
·
Levi J. Rupp
, Kathrin Schumann
, et al.
·
Scientific Reports
·
792
PDF
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape
2019
·
Mohamad Hamieh
, Anton Dobrin
, et al.
·
Nature
·
720
Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells
2015
·
Sanja Stevanović
, Lindsey M. Draper
, et al.
·
Journal of Clinical Oncology
·
710
PDF
A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects
2018
·
Yuki Kagoya
, Shinya Tanaka
, et al.
·
Nature Medicine
·
665
Tuning the Antigen Density Requirement for CAR T-cell Activity
2020
·
Robbie G. Majzner
, Skyler P. Rietberg
, et al.
·
Cancer Discovery
·
618
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation
2018
·
Sonia Guedan
, Avery D. Posey
, et al.
·
JCI Insight
·
610
PDF
Chimeric Antigen Receptors Combining 4-1BB and CD28 Signaling Domains Augment PI3kinase/AKT/Bcl-XL Activation and CD8+ T Cell–mediated Tumor Eradication
2009
·
Xiao-Song Zhong
, Maiko Matsushita
, et al.
·
Molecular Therapy
·
575
PDF
Tissue-resident memory features are linked to the magnitude of cytotoxic T cell responses in human lung cancer
2017
·
Anusha-Preethi Ganesan
, James Clarke
, et al.
·
Nature Immunology
·
555
The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
2009
·
Junko Ozao-Choy
, Ge Ma
, et al.
·
Cancer Research
·
548
PDF
Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies
2017
·
Cariad Chester
, Miguel F. Sanmamed
, et al.
·
Blood
·
518
Immune Stimulatory Receptor CD40 Is Required for T-Cell Suppression and T Regulatory Cell Activation Mediated by Myeloid-Derived Suppressor Cells in Cancer
2009
·
Ping-Ying Pan
, Ge Ma
, et al.
·
Cancer Research
·
496
PDF
Show more works
View as search
Works count:
4,756
Citation count:
113,500
Year
Topic
Type